Cargando…
Author reply: S‐ICD eligibilities in adults with congenital heart disease
Autores principales: | Zormpas, Christos, Silber‐Peest, Ann Sophie, Eiringhaus, Jörg, Hillmann, Henrike A.K., Hohmann, Stephan, Müller‐Leisse, Johanna, Westhoff‐Bleck, Mechthild, Veltmann, Christian, Duncker, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318500/ https://www.ncbi.nlm.nih.gov/pubmed/34121341 http://dx.doi.org/10.1002/ehf2.13467 |
Ejemplares similares
-
Eligibility for subcutaneous implantable cardioverter‐defibrillator in adults with congenital heart disease
por: Zormpas, Christos, et al.
Publicado: (2021) -
Eligibility for subcutaneous implantable cardioverter-defibrillator in patients with left ventricular assist device
por: Zormpas, Christos, et al.
Publicado: (2020) -
Changes in eligibility for a subcutaneous cardioverter-defibrillator after implantation of a left ventricular assist device–A prospective analysis
por: Zormpas, Christos, et al.
Publicado: (2023) -
Premature end of service of implantable cardioverter-defibrillator by magnetic interference with left-ventricular assist device
por: Eiringhaus, Jörg, et al.
Publicado: (2021) -
Feasibility and First Results of Heart Failure Monitoring Using the Wearable Cardioverter–Defibrillator in Newly Diagnosed Heart Failure with Reduced Ejection Fraction
por: Hillmann, Henrike Aenne Katrin, et al.
Publicado: (2021)